ArticlePediatric surgery international2025
Laparoscopic "TOUSSEN" fundoplication for pediatric gastroesophageal reflux disease: a new modified technique gentle as Toupet and solid as Nissen?
Article in Pediatric surgery international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsExisting fundoplication techniques, although effective, may present drawbacks as dysphagia and recurrence. This study presents a new modified Laparoscopic Toussen (TOUpet-niSSEN) Fundoplication (LTF) developed to reduce the risk of dysphagia and recurrence. We aim to report its safety, feasibility and efficacy in the treatment of pediatric Gastroesophageal Reflux Disease (GERD).
methodsA retrospective study was performed on the clinical data, surgical procedures, and follow-up of a cohort of consecutive patients who received LTF at our tertiary center from 2010 to 2023. The LTF combines a 270° Toupet valve at the upper section and a 360° Nissen valve at the lower section. The exclusion criteria encompassed age over 18 years and patients referred for a redo fundoplication. The diagnosis was based on symptoms and radiological/additional exams, corroborated by a multidisciplinary meeting.
resultsOver a span of 13 years, we treated 219 patients (average of 16 LTF each year), including 49 (22%) with neurological impairment and 13 (6%) with esophageal atresia. The median age at surgery was 5.5 years (range: 1.1-17.5 years), and the median weight 18.2 kg (range: 5.5-80 kg). Gastrostomy was performed in 33 instances (15%). The median duration was 70 min (range: 44 to 177 min). No patient required conversion to laparotomy. Intraoperative problems were observed in 0.4% of patients. During the first postoperative month, 13 early complications occurred (6%): 8 dysphagia, 1 bronchopneumonia, 1 removal of the gastrostomy button, 1 bleeding from trocar orifice, 1 umbilical incisional hernia, and 1 self-limiting neurological symptom. The median duration of hospitalization was 2 days (range: 1-45 days). Overall, we monitored 190 patients for at least 6 months, with a median follow-up of 4.5 years (range: 0.6-11 years). Four patients (2%) required additional surgical intervention: two laparoscopic partial valve releases, one redo fundoplication, and one incisional hernia repair.
conclusionsIn this first analysis of the short- and medium-term outcomes, LTF seemed safe and efficacious for the treatment of pediatric GERD. LEVELS OF EVIDENCE: III.
Indexed as
Identifiers
40493216What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.